Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / CL A
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
18,219,983
-
Shares change
-
+583,621
-
Total reported value, excl. options
-
$1,463,018,265
-
Value change
-
+$45,314,802
-
Put/Call ratio
-
192%
-
Number of buys
-
89
-
Number of sells
-
-57
-
Price
-
$80.29
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q3 2019
198 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q3 2019.
REATA PHARMACEUTICALS INC - CL A (RETA) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,219,983 shares
.
Largest 10 shareholders include CPMG Inc (3,023,349 shares), BlackRock Inc. (1,955,230 shares), VANGUARD GROUP INC (1,831,425 shares), FRANKLIN RESOURCES INC (1,255,027 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,014,432 shares), Cormorant Asset Management, LP (819,769 shares), WELLINGTON MANAGEMENT GROUP LLP (514,810 shares), STATE STREET CORP (464,768 shares), Point72 Asset Management, L.P. (360,088 shares), and GEODE CAPITAL MANAGEMENT, LLC (293,953 shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.